Back to Search
Start Over
Fanapt Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study
- Source :
- PR Newswire. December 19, 2022
- Publication Year :
- 2022
-
Abstract
- Supplemental New Drug Application (sNDA) planned for 2023 WASHINGTON, Dec. 19, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported positive results in a Phase III clinical study [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.730572051